Genuine Parts Weighs Business Separation
Atlanta-based Genuine Parts Co. is weighing separating its profitable auto parts unit (63% of sales) from its industrial business after settling with Elliott Investment Management.
NOTRELOAD AI
Oracle in Talks With Meta on $20 Billion AI Cloud Computing Deal
Oracle is negotiating a massive $20B cloud computing deal with Meta to power its AI models. This reinforces Oracle's new role as a major AI infrastructure provider, competing with Amazon and Google.
Major Overhaul Planned for H-1B Visas, Including a $100,000 Fee
President Trump is moving to dramatically change the H-1B visa program with a new, massive application fee and revised wage rules. These changes are aimed at curbing visa overuse and protecting American jobs.
ARS Pharmaceuticals Neffy Nasal Spray Approved in Japan
Japan approved neffy (epinephrine nasal spray). This needle-free option treats severe allergies (anaphylaxis) in adults and kids (>15 kg). It's the first in Japan, offering a compact, injection-free alternative. Availability starts late 2025.
NEXLETOL Gains Approval in Japan: A Major Global Expansion for Esperion
Esperion's cholesterol pill, NEXLETOL, is now approved in Japan through its partner, Otsuka. This major global expansion (now U.S., Europe, Japan) secures Esperion large milestone payments and tiered royalties (15%-30%) on sales.
Verrica's Skin Infection Drug Ycanth Gains Approval in Japan
Verrica's drug Ycanth, which treats the common viral skin infection molluscum contagiosum, gained approval in Japan. This key approval immediately triggers a $10 million cash payment to Verrica, boosting their finances and supporting U.S. sales efforts.